NEW BRIGHTON, Minn., July 18, 2024--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) ("APi") announced today that it intends to release its financial results for the three months ended June 30, 2024, before the market opens on Thursday, August 1, 2024. Second Quarter Earnings Conference Call …
Bombardier Inc. MONTRÉAL, July 18, 2024 (GLOBE NEWSWIRE) -- Bombardier (TSX: BBD.B) will publish its financial results for the second quarter of 2024 on July 25, 2024. Financial results for the second quarter 2024 Éric Martel, President and Chief Executive Officer, Bombardier, and Bart …
Revenues of $4.5 billion (-7% as reported, -3% constant currency) Continuation of challenging environment in North America and Europe during the quarter, solid demand in Latin America and Asia-Pacific region Gross profit margin of 17.4%. Staffing margins remained solid; permanent recruitment levels stepped down …
SAN JUAN, Puerto Rico, July 18, 2024--(BUSINESS WIRE)--OFG Bancorp (NYSE: OFG), the financial holding company for Oriental Bank, today reported results for the second quarter ended June 30, 2024. EPS diluted of $1.08 compared to $1.05 in 1Q24 and $0.93 in 2Q23. Total core …
We feel now is a pretty good time to analyse Rapid7, Inc.'s (NASDAQ:RPD) business as it appears the company may be on the cusp of a considerable accomplishment. Rapid7, Inc. provides cybersecurity solutions under the Rapid7, Nexpose, and Metasploit brand names. The US$2.6b market-cap …
Key Insights Significantly high institutional ownership implies Green Brick Partners' stock price is sensitive to their trading actions 50% of the business is held by the top 8 shareholders Insiders have been selling lately Every investor in Green Brick Partners, Inc. (NYSE:GRBK) should be …
– Two-year Phase III data presented at ASRS 2024 show Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR) – – Safety data were consistent with the known safety profile for Susvimo in people with …
F. Hoffmann-La Roche Ltd Two-year Phase III data presented at ASRS 2024 show Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR) Safety data were consistent with the known safety profile for Susvimo in people …
Upslope Capital Management, an investment management firm, released its second-quarter 2024 investor letter. The firm had a promising start in Q2 but ended with difficulties. A copy of the letter can be downloaded here. There was macro and geopolitical uncertainty, and markets were expensive. …
Hexcel (NYSE:HXL) Posts Better-Than-Expected Sales In Q2 Aerospace and defense company Hexcel (NYSE:HXL) reported Q2 CY2024 results beating Wall Street analysts' expectations , with revenue up 10.1% year on year to $500.4 million. On the other hand, the company's full-year revenue guidance of $1.94 …